<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p103" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_103{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_103{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_103{left:128px;bottom:1109px;letter-spacing:-0.18px;}
#t4_103{left:238px;bottom:1109px;letter-spacing:-0.2px;}
#t5_103{left:238px;bottom:1080px;letter-spacing:-0.01px;}
#t6_103{left:238px;bottom:1061px;letter-spacing:-0.01px;}
#t7_103{left:238px;bottom:1041px;letter-spacing:-0.01px;}
#t8_103{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#t9_103{left:238px;bottom:974px;letter-spacing:-0.01px;}
#ta_103{left:238px;bottom:954px;letter-spacing:-0.01px;}
#tb_103{left:238px;bottom:935px;letter-spacing:-0.01px;}
#tc_103{left:238px;bottom:915px;letter-spacing:-0.01px;}
#td_103{left:238px;bottom:896px;letter-spacing:-0.01px;}
#te_103{left:238px;bottom:829px;letter-spacing:-0.01px;}
#tf_103{left:238px;bottom:809px;letter-spacing:-0.01px;}
#tg_103{left:238px;bottom:790px;letter-spacing:-0.01px;}
#th_103{left:238px;bottom:742px;letter-spacing:-0.01px;}
#ti_103{left:238px;bottom:722px;letter-spacing:-0.01px;}
#tj_103{left:238px;bottom:674px;letter-spacing:-0.01px;}
#tk_103{left:293px;bottom:645px;}
#tl_103{left:321px;bottom:645px;letter-spacing:-0.01px;}
#tm_103{left:293px;bottom:616px;}
#tn_103{left:321px;bottom:616px;letter-spacing:-0.01px;}
#to_103{left:321px;bottom:597px;letter-spacing:-0.01px;}
#tp_103{left:293px;bottom:567px;}
#tq_103{left:321px;bottom:567px;letter-spacing:-0.01px;}
#tr_103{left:321px;bottom:548px;letter-spacing:-0.01px;}
#ts_103{left:321px;bottom:529px;letter-spacing:-0.01px;}
#tt_103{left:293px;bottom:480px;}
#tu_103{left:321px;bottom:480px;letter-spacing:-0.01px;}
#tv_103{left:293px;bottom:431px;}
#tw_103{left:321px;bottom:431px;letter-spacing:-0.01px;}
#tx_103{left:293px;bottom:402px;}
#ty_103{left:321px;bottom:402px;letter-spacing:-0.01px;}
#tz_103{left:321px;bottom:383px;letter-spacing:-0.01px;}
#t10_103{left:293px;bottom:334px;}
#t11_103{left:321px;bottom:334px;letter-spacing:-0.01px;}
#t12_103{left:128px;bottom:285px;letter-spacing:-0.18px;}
#t13_103{left:238px;bottom:285px;letter-spacing:-0.2px;}
#t14_103{left:238px;bottom:257px;letter-spacing:-0.01px;}
#t15_103{left:238px;bottom:237px;letter-spacing:-0.01px;}
#t16_103{left:238px;bottom:218px;letter-spacing:-0.01px;}
#t17_103{left:238px;bottom:170px;letter-spacing:-0.01px;}
#t18_103{left:238px;bottom:150px;letter-spacing:-0.01px;}
#t19_103{left:238px;bottom:131px;letter-spacing:-0.01px;}
#t1a_103{left:238px;bottom:112px;letter-spacing:-0.01px;}
#t1b_103{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_103{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_103{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_103{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_103{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_103{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts103" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg103Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg103" style="-webkit-user-select: none;"><object width="908" height="1286" data="103/103.svg" type="image/svg+xml" id="pdf103" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_103" class="t s0_103">7.9. Supportive therapy </span><span id="t2_103" class="t s1_103">103 </span>
<span id="t3_103" class="t s2_103">7.9.3. </span><span id="t4_103" class="t s2_103">Side effects and their treatment in targeted therapy </span>
<span id="t5_103" class="t s3_103">The increasing number of patients treated with targeted therapies that induce specific </span>
<span id="t6_103" class="t s3_103">cutaneous side effects requires good management and interdisciplinary collaboration </span>
<span id="t7_103" class="t s3_103">between dermatologists and oncologists from other disciplines so that therapy can be </span>
<span id="t8_103" class="t s3_103">maintained as planned. [367] </span>
<span id="t9_103" class="t s3_103">Cutaneous side effects are seen in up to 34% of patients with multikinase inhibitors, in up to </span>
<span id="ta_103" class="t s3_103">90% with selective kinase inhibitors such as EGFR inhibitors and inhibitors of mutated BRAF, and </span>
<span id="tb_103" class="t s3_103">in up to 68% with immunotherapeutic agents such as CTLA-4 blockers. These side effects can </span>
<span id="tc_103" class="t s3_103">correlate with the response to therapy, but they can also limit drug tumor therapy due to their </span>
<span id="td_103" class="t s3_103">localization in visible areas of the body or due to their severity [368]. </span>
<span id="te_103" class="t s3_103">The frequency of cutaneous side effects during targeted therapy requires correct and early </span>
<span id="tf_103" class="t s3_103">diagnosis and optimal side effect management, since deficits in this area can jeopardize </span>
<span id="tg_103" class="t s3_103">patient adherence to therapy and thus the success of therapy [369]. </span>
<span id="th_103" class="t s3_103">Although certain measures cannot prevent the development of side effects on the skin, they </span>
<span id="ti_103" class="t s3_103">can influence their severity and prevent possible complications. </span>
<span id="tj_103" class="t s3_103">The following advice for patients is generally accepted: </span>
<span id="tk_103" class="t s4_103">• </span><span id="tl_103" class="t s3_103">Use only water and soap-free lotions to clean the skin </span>
<span id="tm_103" class="t s4_103">• </span><span id="tn_103" class="t s3_103">Do not wash your skin unnecessarily (no long showers or baths), only use </span>
<span id="to_103" class="t s3_103">lukewarm water </span>
<span id="tp_103" class="t s4_103">• </span><span id="tq_103" class="t s3_103">The use of nourishing lotions or creams should be discussed with the doctor, even </span>
<span id="tr_103" class="t s3_103">if they are not prescription-only. Not every preparation is helpful in every phase of </span>
<span id="ts_103" class="t s3_103">skin changes. Ointments containing fat are often harmful. </span>
<span id="tt_103" class="t s4_103">• </span><span id="tu_103" class="t s3_103">Avoid high room temperatures, increase humidity if skin is dry </span>
<span id="tv_103" class="t s4_103">• </span><span id="tw_103" class="t s3_103">Adequate light protection, avoidance of direct sunlight </span>
<span id="tx_103" class="t s4_103">• </span><span id="ty_103" class="t s3_103">Wear light, breathable and non-constricting clothing / Wear loose shoes to avoid </span>
<span id="tz_103" class="t s3_103">pressure on the nail bed / Wear cotton-lined gloves when doing housework </span>
<span id="t10_103" class="t s4_103">• </span><span id="t11_103" class="t s3_103">Gentle, careful nail care, do not push back cuticles </span>
<span id="t12_103" class="t s2_103">7.9.4. </span><span id="t13_103" class="t s2_103">Side effects and their treatment during surgery </span>
<span id="t14_103" class="t s3_103">In contrast to complications, side effects are typical symptoms after surgery that are always </span>
<span id="t15_103" class="t s3_103">to be expected, even if they occur in varying degrees. Surgical treatment of laryngeal </span>
<span id="t16_103" class="t s3_103">carcinoma always leads to functional impairments of varying degrees. </span>
<span id="t17_103" class="t s3_103">The least functional disturbances occur after transoral laser surgical resection of T1 carcinomas </span>
<span id="t18_103" class="t s3_103">of the vocal cords. The dysphonia that occurs after this usually disappears significantly after a </span>
<span id="t19_103" class="t s3_103">few weeks, supported by speech therapy. After laser surgical resection of T2 carcinomas, in </span>
<span id="t1a_103" class="t s3_103">which a </span>
<span id="t1b_103" class="t s0_103">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
